NASDAQ:ATAI
ATA Inc. Stock News
$1.84
-0.0300 (-1.60%)
At Close: Apr 25, 2024
atai Life Sciences to Announce Second Quarter 2022 Financial Results and Business Update
10:59am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
NEW YORK and BERLIN, Aug. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental hea
atai Life Sciences legt Finanzergebnisse für das zweite Quartal 2022 und Unternehmens-Update vor
10:59am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
NEW YORK (USA) und BERLIN, Aug. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen im klinischen Stadium, das anstrebt, die Behandl
The Growth Potential Of Psychedelics Stocks And ETFs
01:54pm, Thursday, 28'th Jul 2022
On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan
New Regulations for Psychedelics? Here's What Investors Need to Know
10:40am, Friday, 22'nd Jul 2022 The Motley Fool
There are a couple of proposed regulations and policies in the pipeline.
New Regulations for Psychedelics? Here's What Investors Need to Know
06:40am, Friday, 22'nd Jul 2022
There are a couple of proposed regulations and policies in the pipeline.
5 Top Stocks Cathie Wood Bought This Week
05:12pm, Friday, 15'th Jul 2022
Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week.
Atai Life Sciences: Leading But Early Stage Psychedelic Therapeutics Developer
02:24pm, Thursday, 07'th Jul 2022
ATAI is backed by Peter Thiel. Its decentralized business model is pretty unique.
Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead
11:31am, Wednesday, 06'th Jul 2022 Benzinga
As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys Ltd. (NASDAQ: SSY
Bright Green, Staffing 360 Solutions And 3 Stocks To Watch Heading Into Tuesday
08:06am, Tuesday, 05'th Jul 2022 Benzinga
With the US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Bright Green Corporation (NASDAQ: BGXX) disclosed that the CEO
Will Tech Stocks Recover? 3 Names To Buy
08:30am, Friday, 01'st Jul 2022
Tech stocks have crashed, but Wall Street should eventually remember why the love affair began in the first place. After the tech crash, it makes sense to invest in a large quantity of names.
Kures Therapeutics, ein Unternehmen von atai Life Sciences, ernennt Dr. Chad Beyer zum CEO
12:40pm, Thursday, 30'th Jun 2022 GlobeNewswire Inc.
Dr. Chad Beyer wird am 1. Juli 2022 als CEO antreten Dr. Chad Beyer wird am 1. Juli 2022 als CEO antreten
atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer
10:59am, Thursday, 30'th Jun 2022 GlobeNewswire Inc.
Dr. Chad Beyer will join as CEO on July 1, 2022 Dr. Chad Beyer will join as CEO on July 1, 2022
10 Psychedelics CEOs To Pay Attention To In 2022
06:51pm, Tuesday, 28'th Jun 2022 Benzinga
By Javier Hasse and Aaron Bry.
2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both
US Senate Moves Forward On Gun Reform: 3 Stocks That Could Benefit As A Result
12:27pm, Wednesday, 22'nd Jun 2022 Benzinga
Tuesday night, the U.S. Senate finally cleared a procedural vote to move forward with gun control legislation. The action comes after weeks of negotiations.
In order to pass, the deal needed bipartis
Stephen Bardin kommt als designierter CFO zu atai Life Sciences
01:19pm, Saturday, 18'th Jun 2022 GlobeNewswire Inc.
NEW YORK and BERLIN, June 18, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V., (Nasdaq: ATAI) („atai“ oder das „Unternehmen“), ein Unternehmen für Biopharmazeutika im klinischen Stadium, d